These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 6530354)

  • 1. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
    Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
    Komaki R; Lee JS; Milas L; Lee HK; Fossella FV; Herbst RS; Allen PK; Liao Z; Stevens CW; Lu C; Zinner RG; Papadimitrakopoulou VA; Kies MS; Blumenschein GR; Pisters KM; Glisson BS; Kurie J; Kaplan B; Garza VP; Mooring D; Tucker SL; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1369-77. PubMed ID: 15050312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
    Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer.
    Wolf M; Hans K; Becker H; Hässler R; von Bültzingslöwen F; Goerg R; Klaasen HA; Dannhäuser J; Holle R; Pfab R
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):42-7. PubMed ID: 8209276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer.
    Park JO; Kim SW; Ahn JS; Suh C; Lee JS; Jang JS; Cho EK; Yang SH; Choi JH; Heo DS; Park SY; Shin SW; Ahn MJ; Lee JS; Yun YH; Lee JW; Park K
    J Clin Oncol; 2007 Nov; 25(33):5233-9. PubMed ID: 18024869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.
    Wu C; Jiang J; Shi L; Xu N
    Anticancer Res; 2008; 28(6B):3997-4002. PubMed ID: 19192663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
    Sculier JP; Paesmans M; Lecomte J; Van Cutsem O; Lafitte JJ; Berghmans T; Koumakis G; Florin MC; Thiriaux J; Michel J; Giner V; Berchier MC; Mommen P; Ninane V; Klastersky J;
    Br J Cancer; 2001 Nov; 85(10):1444-51. PubMed ID: 11720426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study on quality of life between weekly and monthly chemotherapy with cisplatin, vindesine and mitomycin C in patients with non-small cell lung cancer].
    Ishihara Y; Ichiwata T; Kuramitsu K; Yoneda S; Yamamoto M; Takizawa T; Ogata T; Uchiyama T; Yoshida K
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1013-20. PubMed ID: 9644316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer.
    Lorigan P; Woll PJ; O'Brien ME; Ashcroft LF; Sampson MR; Thatcher N
    J Natl Cancer Inst; 2005 May; 97(9):666-74. PubMed ID: 15870437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).
    Lilenbaum RC; Herndon JE; List MA; Desch C; Watson DM; Miller AA; Graziano SL; Perry MC; Saville W; Chahinian P; Weeks JC; Holland JC; Green MR
    J Clin Oncol; 2005 Jan; 23(1):190-6. PubMed ID: 15625373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination chemotherapy with Taxol and cisplatin for 57 patients with non-small cell lung cancer by intraartery and intravenous infusion].
    Zhao Y; Wang SM; Zhang J
    Ai Zheng; 2002 Dec; 21(12):1365-7. PubMed ID: 12520750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experience with thymostimulin (TP-1) therapy. Preliminary findings].
    Altomonte L; Zoli A; Siena D; Alessi F; Pestillo L; Mirone L
    Minerva Med; 1986 Jun; 77(26):1243-7. PubMed ID: 3725151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of thymostimulin in lymphoma and myeloma patients].
    Cánovas Fernández A; Alonso Alonso J; González de Zárate P; García Masdevall MD; Riñón Martínez-Gallo M; Aguirre Errasti C
    An Med Interna; 1991 Feb; 8(2):69-73. PubMed ID: 1893006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymostimulin prophylaxis of postoperative infections in anergic patients.
    Farina EC; Garino M; Balbo G
    Can J Surg; 1986 Nov; 29(6):445-6. PubMed ID: 3536050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of urinary tract infections following endoscopic surgery in immunodepressed patients treated with thymostimulin.
    Cocimano V; Casetta G; Piana P; Tizzani A
    J Exp Pathol; 1987; 3(4):607-11. PubMed ID: 3454808
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymic peptides for treatment of cancer patients.
    Wolf E; Milazzo S; Boehm K; Zwahlen M; Horneber M
    Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD003993. PubMed ID: 21328265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary immunodeficiency in advanced lung cancer: effects of chemotherapy plus thymostimulin in immunodepressed patients: updating results.
    Del Giacco GS; Mantovani G; Cengiarotti L; Puxeddu G; Pischedda A; Di Tucci A; Vespa F
    Int J Tissue React; 1984; 6(6):499-504. PubMed ID: 6530354
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.